New York, drug distributors reach $1.18 billion opioid settlement as national deal looms
The three largest US drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nation-wide opioid epidemic, the state’s attorney general said 20th.
July 22, 2021
by expresspharma
Regeneron to invest $1.8bn to expand facilities in New York
Regeneron Pharmaceuticals has plans to invest nearly $1.8bn to boost research, preclinical production and support sites at its Westchester County campus in Tarrytown, New York, US.
July 19, 2021
by pharmaceutical-technology
New York State to Ban Flavored E-Cigarettes
Using his executive powers, New York Governor Andrew Cuomo has ordered a ban on most flavored electronic cigarettes in the state.
September 17, 2019
by drugs
Officials Say New York City Measles Outbreak Over
The New York City measles outbreak is over and the public health emergency that was declared on April 9 for parts of Brooklyn has ended, New York Mayor Bill de Blasio said Tuesday.
September 4, 2019
by drugs
Regeneron plots $800M New York production push—along with 1,500 new jobs
Regeneron is humming along on the strength of flagship eye med Eylea and fast-launching immunology drug Dupixent. Now, the drugmaker is investing $800 million in its New York operations to keep up with the growth.
August 15, 2019
by fiercepharma
New York State Halts Religious Vaccine Exemption
New York State Halts Religious Vaccine Exemption.
June 17, 2019
by drugs
Breathe Easier, New York City: Clean-Air Taxi Rules Are Working
Clean-air taxi rules in New York City increased cabs' fuel efficiency and reduced air pollution, a new study says.
May 30, 2019
by drugs
New York City Measles Cases Increase to 390
The number of measles cases in New York City has risen to 390, the health department said Wednesday.
April 25, 2019
by drugs
Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointment of Robert J. Mi
September 29, 2018
by pharmafocusasia
Regeneron continues New York expansion with $800M project, 1,500 jobs
Regeneron is supersizing a campus expansion in New York, investing $800 million and adding 1,500 jobs and winning a substantial tax break in the process.
September 14, 2018
by fiercepharma
Y-mAbs preps $92M IPO to push lead assets through regulatory filing
Naxitamab and omburtamab are in pivotal phase 2 studies for relapsed/refractory high-risk neuroblastoma and central nervous system/leptomeningeal metastases from neuroblastoma, respectively. (Y-mAbs Therapeutics)
August 28, 2018
by fiercebiotech